| Literature DB >> 23937452 |
Ariel Shusterman1, Yasser Salyma, Aysar Nashef, Morris Soller, Asaf Wilensky, Richard Mott, Ervin I Weiss, Yael Houri-Haddad, Fuad A Iraqi.
Abstract
BACKGROUND: Periodontal infection (Periodontitis) is a chronic inflammatory disease, which results in the breakdown of the supporting tissues of the teeth. Previous epidemiological studies have suggested that resistance to chronic periodontitis is controlled to some extent by genetic factors of the host. The aim of this study was to determine the phenotypic response of inbred and Collaborative Cross (CC) mouse populations to periodontal bacterial challenge, using an experimental periodontitis model. In this model, mice are co-infected with Porphyromonas gingivalis and Fusobacterium nucleatum, bacterial strains associated with human periodontal disease. Six weeks following the infection, the maxillary jaws were harvested and analyzed for alveolar bone loss relative to uninfected controls, using computerized microtomography (microCT). Initially, four commercial inbred mouse strains were examined to calibrate the procedure and test for gender effects. Subsequently, we applied the same protocol to 23 lines (at inbreeding generations 10-18) from the newly developed mouse genetic reference population, the Collaborative Cross (CC) to determine heritability and genetic variation of control bone volume prior to infection (CBV, naïve bone volume around the teeth of uninfected mice), and residual bone volume (RBV, bone volume after infection) and loss of bone volume (LBV, the difference between CBV and RBV) following infection.Entities:
Mesh:
Year: 2013 PMID: 23937452 PMCID: PMC3751202 DOI: 10.1186/1471-2156-14-68
Source DB: PubMed Journal: BMC Genet ISSN: 1471-2156 Impact factor: 2.797
Test for gender differences
| BALB/cJ | CBV | 5 | 6.56 | 0.60 | 5 | 5.98 | 0.21 | 0.39 |
| | RBV | 4 | 4.37 | 0.28 | 5 | 4.68 | 0.33 | 0.54 |
| | LBV | | 2.19 | 0.66 | | 1.30 | 0.39 | |
| C57BL/6J | CBV | 5 | 5.50 | 0.82 | 4 | 3.75 | 0.22 | 0.11 |
| | RBV | 3 | 5.10 | 0.50 | 4 | 4.60 | 0.44 | 0.49 |
| | LBV | | 0.40 | 0.96 | | −0.85 | 0.49 | |
| A/J | CBV | 5 | 7.32 | 0.49 | 5 | 6.96 | 0.61 | 0.66 |
| | RBV | 5 | 7.20 | 0.42 | 5 | 7.68 | 0.43 | 0.45 |
| | LBV | | 0.12 | 0.65 | | 0.72 | 0.75 | |
| DBA/2J | CBV | 4 | 6.52 | 0.25 | 3 | 7.53 | 0.88 | 0.26 |
| | RBV | 5 | 6.64 | 0.25 | 4 | 6.95 | 0.43 | 0.52 |
| | LBV | | −0.12 | 0.35 | | 0.58 | 0.98 | |
| CC034/TAU | CBV | 8 | 3.35 | 0.45 | 2 | 3.85 | 0.75 | 0.62 |
| | RBV | 5 | 3.62 | 0.39 | 2 | 5.05 | 0.95 | 0.14 |
| | LBV | | −0.27 | 0.60 | | −0.12 | 1.21 | |
| CC188/TAU | CBV | 2 | 6.35 | 0.15 | 3 | 4.83 | 0.44 | 0.08 |
| | RBV | 2 | 5.15 | 0.05 | 3 | 5.80 | 0.71 | 0.53 |
| | LBV | | 1.20 | 0.16 | | −0.97 | 0.84 | |
| CC711/TAU | CBV | 6 | 6.52 | 0.62 | 7 | 6.10 | 0.64 | 0.65 |
| | RBV | 4 | 4.93 | 0.69 | 6 | 4.72 | 0.85 | 0.87 |
| LBV | 1.59 | 0.93 | 1.38 | 1.06 | ||||
Comparison of control bone volume before infection (CBV), and residual bone volume (RBV) and loss of bone volume (LBV) following infection in males and females. Results are shown for four standard laboratory pure lines, and for three randomly chosen TAU CC lines.
CBV Control Bone Volume.
RBV Residual Bone Volume.
No. number of mice.
SE standard error.
* = × 10-3mm3.
Figure 1Residual alveolar bone volume (RBV) following infection (RBV) in BALB/c mice across five independent trials (A through E, gray bars) compared to control bone volume (CBV) before infection, in Trial 1 (black bar). Differences among trials, not including control, NS (P=0.57). Differences among trials including control, highly significant (P=0.004).
Characteristics of four standard laboratory pure lines with respect to control bone volume before infection (CBV), and residual bone volume (RBV) and loss of bone volume (LBV) following infection
| BALB/cJ | 12 | 6.27a,b | 9 | 4.54a | 9 | 1.73b** |
| C57Bl/6J | 9 | 4.72a | 7 | 4.81a | 7 | −0.09a,b |
| A/J | 10 | 7.14b | 10 | 7.44b | 10 | −0.30a |
| DBA/2J | 7 | 6.95b | 9 | 6.78b | 7 | 0.17a,b |
CBV Control Bone Volume.
RBV Residual Bone Volume.
No. number of mice.
* = × 10-3mm3.
** = loss of bone volume following infection significant at P<0.01.
a,b = Lines within a column that share the same superscript letter do not differ significantly by Duncan’s Least Significant Range test.
Comparison of 23 TAU CC lines with respect to control bone volume before infection (CBV), and residual bone volume (RBV) and loss of bone volume (LBV) following infection
| CC01 | CC026/TAU | 4 | 10.68d,e | 6 | 6.65c,d,e | 4.03c,d*** |
| CC02 | CC030/TAU | 8 | 7.05b,c | 9 | 5.90b,c,d | 1.15a,b,c,d |
| CC03 | CC034/TAU | 10 | 3.45 a | 4 | 3.45a,b | 0a,b |
| CC04 | CC057/TAU | 3 | 11.10d,e | 5 | 6.44c,d,e | 4.66d*** |
| CC05 | CC072/TAU | 12 | 6.28a,b | 11 | 4.72a,b,c | 1.56a,b,c,d*** |
| CC06 | CC111/TAU | 8 | 6.34a,b | 6 | 5.80b,c,d | 0.54a,b,c |
| CC07 | CC114/TAU | 5 | 7.98b,c | 6 | 10.12e,f | −2.14a |
| CC08 | CC182/TAU | 5 | 10.70d,e | 5 | 6.02c,d | 4.68d*** |
| CC09 | CC188/TAU | 5 | 5.44 a | 5 | 5.54b,c,d | −0.10a,b |
| CC10 | CC196/TAU | 8 | 8.19b,c,d | 8 | 6.13c,d | 2.06b,c,d*** |
| CC11 | CC211/TAU | 4 | 5.88a,b | 6 | 5.50b,c | 0.38a,b,c |
| CC12 | CC219/TAU | 5 | 5.62a,b | 5 | 4.46a,b | 1.16a,b,c,d |
| CC13 | CC521/TAU | 7 | 5.89a,b | 5 | 5.50b,c | 0.39a,b,c |
| CC14 | CC530/TAU | 4 | 5.58a,b | 3 | 6.03c,d | −0.45a,b |
| CC15 | CC534/TAU | 3 | 6.0a,b | 4 | 5.55b,c,d | 0.45a,b,c |
| CC16 | CC551/TAU | 6 | 3.72a | 7 | 2.64a | 1.08a,b,c,d |
| CC17 | CC611/TAU | 4 | 5.83a,b | 6 | 4.90a,b,c | 0.93a,b,c,d |
| CC18 | CC643/TAU | 5 | 6.08a,b | 3 | 6.07c,d | 0.01a,b |
| CC19 | CC670/TAU | 6 | 9.93c,d,e | 4 | 8.53e,f | 1.40a,b,c,d |
| CC20 | CC688/TAU | 3 | 3.70a | 5 | 4.54a,b,c | −0.84a,b |
| CC21 | CC696/TAU | 6 | 8.30b,c,d,e | 4 | 8.20d,e | 0.10a,b |
| CC22 | CC711/TAU | 13 | 6.29a,b | 10 | 4.8a,b,c | 1.49a,b,c,d** |
| CC23 | CC785/TAU | 5 | 6.50a,b | 6 | 5.17a,b,c | 1.33a,b,c,d |
| Mean/Total SD | 139 | 6.80 | 133 | 5.77 | 1.13 | |
| 2.17 | 1.59 | 1.63 | ||||
CBV Control Bone Volume.
RBV Residual Bone Volume.
LBV Loss of Bone volume.
No. number of mice.
* = × 10-3mm3.
** = P <0.01.
*** = P <0.001.
a,b,c,d,e,f = Lines within a column that share the same superscript letter do not differ significantly by Duncan’s Least Significant Range test.
Heritability calculations for CBV, RBV and LBV
| MS Between* | 24.09 | 14.08 | 12.21 |
| MS within=VarE | 4.58 | 2.82 | 5.21 |
| P-value | <0.001 | <0.001 | 0.002 |
| No. | 6.32 | 6.05 | 5.32 |
| VarG | 3.09 | 1.86 | 1.32 |
| H2 | 0.40 | 0.40 | 0.20 |
CBV Control Bone Volume.
RBV Residual Bone Volume.
LBV Loss of Bone volume.
No. = average number of progeny/line.
* = × 10-3mm3.
d.f. Between = 22 for all treatments;
d.f. Within = 116, 110, and 94 for CBV, RBV and LBV, respectively.
MS between and MS within: Mean square between CC lines and within CC lines as obtained from one-way ANOVA.
VarE and VarG = environmental and genetic components of variance, respectively.
H2= estimate of broad sense heritability.
Figure 2Collaborative Cross (CC) strains arranged in increasing order of mean magnitude. A: Control bone volume before infection (CBV); B: Residual bone volume following infection (RBV); C: Loss of bone volume following infection (LBV). Horizontal lines labeled A to E indicate groups of CC strains that carry the same superscript letter. For example, in Figure 2A, strain CC12 is underlined by lines A and B. This tells us that it carries superscript letters A and B; on the same rules, Strain CC19 carries superscript letters C, D, E, and so on for the other CC strains. Strains that carry the same superscript letters do not differ significantly from one another by Duncan’s Least Significant Range (LSR) test. Thus, Strain CC12 does not differ significantly from any of the strains ranging from CC03 on the left to CC21 on the right, but does differ from Strains CC19 and up. Strain CC19, does not differ from strains ranging from CC02 on the left to CC04 on the right, but does differ from Strains CC23 and down. CBV = Control Bone Volume; RBV = Residual Bone Volume; LBV = Loss of Bone volume. All mean values should be multiplied by ×10-3 mm3.
Figure 3Left mouse hemi-maxillae as reconstructed by micro- chromatography (micro-CT) of mice from line CC026/TAU of the Collaborative Cross mouse population. Upper frame, entire uninfected left-hemi maxilla. Lower left frame, expanded view of uninfected left hemi-maxilla. Lower right frame, expanded view of post-infection left hemi-maxilla. White, enamel; yellow, dentin and cementum; gray, alveolar bone. Horizontal resorption is measured as the distance from the cemento-enamel junction (CEJ, the line between the yellow and gray colors) to the alveolar bone crest.